Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank67
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-15.23
↑ 65% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-43.94
Historical baseline
PeriodValueYoY Change
2025-15.23+17.4%
2024-18.44-164.9%
2023-6.96+1.7%
2022-7.08+59.9%
2021-17.67+79.6%
2020-86.58+44.4%
2019-155.65-